Page 35 - Latest Updates on Trump tariffs

Trump tariffs raise alarm, but how dependent is India on US imports

India's exposure to US imports is limited, but sectors like aerospace, LNG, and high-end tech remain strategically vulnerable

No instructions from govt to stop or continue buying Russian oil: HPCL head

The Indian government has neither directed its oil companies to halt nor continue the purchase of Russian oil, instead allowing them the freedom to make procurement decisions purely based on economic considerations, HPCL's chairman said on Friday. Russian crude oil made up for just 13.2 per cent of all the crude that Hindustan Petroleum Corporation Ltd (HPCL) processed into fuels like petrol and diesel in the April-June quarter, and a complete stoppage of oil from Moscow will not have any "significant" impact, HPCL chairman Vikas Kaushal said at an investor call. US President Donald Trump earlier this week announced he would impose an additional 25 per cent tariff on US imports from India -- raising the overall duty to 50 per cent -- as a penalty for the country's continued imports of Russian oil. Since the steep tariffs are likely to hit the USD 27 billion of non-exempt exports that India does to the US, there has been chatter around stopping or curtailing oil imports from ...

Rupee reverses early gains to end marginally higher amid tariff jitters

Indian Rupee today: The domestic currency closed 4 paise higher at 87.66 against the dollar on Friday, according to Bloomberg

Stock market close highlights: Sensex down 765 pts, Nifty at 24,363; SMIDs, metal, realty top drag

Stock market close highlights, August 8: On the BSE, NTPC, Titan and Trent were the top gainers while Bharti Airtel, Tata Motors and M&M were among the major laggards.

US Democrat slams Trump over 50% tariff on India, says risks years of work

Prominent US Congressman and Democrat Gregory Meeks said the US has deep economic, and people-to-people ties with India, and trade concerns should be addressed in a mutually respectful way

Bruised by Trump, Modi trying to portray himself as farmers' champion: Cong

Now that he is "bruised and battered" by the "Trump onslaught", Prime Minister Narendra Modi is trying to portray himself as the great champion of Indian farmers, but "nobody is fooled", the Congress said on Friday. After US President Donald Trump doubled trade tariffs on India to 50 per cent over its crude oil imports from Russia, Modi on Thursday said India will never compromise on the interests of its farmers and that he was prepared to bear a significant personal cost if necessary. Congress general secretary in-charge communications Jairam Ramesh said there was a time five years ago when the PM mocked protesting farmers as 'andolanjeevi' in Parliament. "Over 700 farmers were martyred in the agitation against the three black anti-farmer laws and the PM had no word expressing pain or regret or sympathy," Ramesh said on X. Farmers' organisations continue to demand a legal guarantee for minimum support price (MSP) set on the Swaminathan formula of the comprehensive cost of cultivat

US links India tariff hike to 'national security' over Russian oil imports

White House Trade Adviser Peter Navarro links extra 25% tariffs on India to its refusal to stop buying Russian oil, calling it a national security threat amid ongoing US-India trade tensions

Moody's warns US 50% tariffs could erode India's manufacturing growth

Credit rating agency says India's manufacturing growth momentum and electronics competitiveness are at risk if tariff dispute with US persists

In an uncertain world, India's small businesses are sure about growth

MSMEs hopeful about first quarter performance and most don't think US tariffs will affect them

IT sector braces for slower growth trajectory as US tariff tensions mount

Sectors such as automobile, manufacturing, and retail are already bearing the brunt of tariffs - this was called out by IT executives during their earnings conferences last month

US calls India strategic partner, vows dialogue despite trade tensions

The US affirms full dialogue with India amid tariff disputes and Russian oil concerns, emphasising direct engagement to resolve differences, while reiterating New Delhi's status as a strategic partner

How the US chose not to bully China but singled out India in trade war

The Indian establishment, which largely welcomed Trump's ascent to power and genuinely believed that the two were on the cusp of a mutually beneficial deal, seems somewhat shell-shocked

Trump's 50% tariff on Indian imports is a US sanction in disguise

A sanction masquerading as tariff is just Trump being innovative

Rupee may test 88.5 levels amid tariff tensions, FPI selloff: Analysts

Indian Rupee outlook: Analysts suggest that the local unit might largely stay range-bound between 86.50 to 88.50 levels

Rupee advances even as tariff rift continues; opens higher at 87.55/$

Indian Rupee today: The domestic currency opened 15 paise higher at 87.55 against the dollar on Friday, according to Bloomberg

US confirmed end to stacking, car tariff cuts in trade talks, says Japan

Japan was hit with higher-than-expected universal tariffs as part of the wave of new levies introduced by the Trump administration Thursday

Trump rules out trade talks with India until tariff dispute resolved

Trump rules out trade talks with India as US imposes 50% tariffs, citing Russian oil imports

Trump tariffs hit India's garment makers as US buyers say move production

A 50% US tariff on Indian garments, tied to Russian oil purchases, has shocked buyers and suppliers, prompting plans to shift production to countries like Ethiopia and Nepal

US tariff: Shrimp biz worth ₹25K cr at stake; farm gate rates drop 19%

Trump's 50% tariff on Indian seafood exports leads to sharp drop in shrimp prices, hurting farmer income in Andhra Pradesh and Odisha; industry urges diversification

Medical devices industry raises concerns over additional 25% US tariff

With US duties on Indian medical devices now at 50%, industry groups warn of trade instability, lost competitiveness, and adverse impact on American patients